WATSON 414 (Estropipate 0.75 mg)

Pill with imprint WATSON 414 is Yellow, Round and has been identified as Estropipate 0.75 mg. It is supplied by Watson Pharmaceuticals.

Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 414

Estropipate

Imprint

WATSON 414

Strength

0.75 mg

Color

Yellow

Shape

Round

Availability

Prescription only

Drug Class

Estrogens

Pregnancy Category

X - Not for use in pregnancy

CSA Schedule

Not a controlled drug

Labeler / Supplier

Watson Pharmaceuticals

National Drug Code (NDC)

52544-0414 (Discontinued)

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer